Aardvark Labs Aardvark Labs Capital Research Reports Tickers Models Calendar About & Disclosures Log in 中文日本語한국어

← All companies

Oracle Corporation

Oracle Corporation (ORCL)

📊 Download Model

Outperform Current rating · 7 reports

2026-06-10

Outperform Recap: Q4 FY26

The Backlog Says $638B, the Cash Flow Says −$24B: Record RPO and a $90B FY27 Guide Collide With a $55.7B Capex Bill and a $40B Raise — Maintaining Outperform

2026-03-11

Outperform Recap: Q3 FY26

A Clean, Gain-Free Beat Ends the Slide: OCI Accelerates to +84%, the $30B Funding Plan Lands, and ORCL Rallies 9%. Maintaining Outperform

2025-12-11

Outperform Recap: Q2 FY26

RPO Vaults to $523B and OCI Reaccelerates to +68%, but a Capex Shock to ~$50B and −$10B Free Cash Flow Sink the Stock 11%: Maintaining Outperform

2025-09-10

Outperform Recap: Q1 FY26

RPO Inflects to $455B, OCI Guide Laid Out at $144B by FY30 — the OpenAI / Stargate Reset: Maintaining Outperform, FV $310–360

2025-06-12

Outperform Recap: Q4 FY25

Maintaining Outperform: Headline Beat, RPO $138B, and an FY26 Raise to >$67B Confirm the Bookings-to-Revenue Cascade Is Delivering

2025-03-11

Outperform Recap: Q3 FY25

Upgrading to Outperform: $48B In-Quarter Bookings, RPO $130B (+63% cc), and FY27 Acceleration to ~20% Tick All Four Boxes From Our Initiation Note

2024-12-10

Hold Recap: Q2 FY25

Initiating Coverage at Hold: RPO Step-Function to $97.3B (+50%) and OCI +52% Validate the Hyperscale Pivot, But Capex Absorption and AI Customer Concentration Keep Us Patient

The depth and quality Wall Street pays for — free.

Missed the earnings call? Don't miss our breakdown.

About & Disclosures · Privacy · Terms

© 2026 Aardvark Labs Capital Research. All rights reserved.